EXPRES2ION BIOTECH HOLDING AB

Insiders ExpreS2ion Biotech Holding AB

Equities

EXPRS2

SE0008348262

Delayed Nasdaq Stockholm Other stock markets 06:29:58 17/05/2024 pm IST			5-day change	1st Jan Change
1.402 ^SEK	-1.41%		-4.63%	-33.55%

16/05	ExpreS2ion Biotech Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
16/04	ExpreS2ion Announces Completion of GLP Safety Study for ES2B-C001 (HER2-VLP) Breast Cancer Vaccine Candidate	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ExpreS2ion Biotech Holding AB Announces Changes to Leadership Team	27/23/27	CI
ExpreS2ion Biotech Names Chief Scientific Officer	03/23/03	MT
ExpreS2ion Biotech Holding AB Appoints Dr. Farshad Guirakhoo as Chief Scientific Officer, Effective January 16, 2023	03/23/03	CI
ExpreS2ion Biotech Holding AB Announces Resignation of Allan Rosetzsky from the Board of Directors	06/22/06	CI
ExpreS2ion Biotech Holding AB Appoints Mattis F. Ranthe as New Chief Medical Officer, Effective February 1, 2022	21/21/21	CI
ExpreS2ion Biotech Holding AB Announces Board Changes	26/21/26	CI
ExpreS2ion Biotech Holding AB Announces Resignation of Gitte L. Pedersen from the Board of Directors	26/21/26	CI
ExpreS2ion Biotech Holding AB Announces Management Changes	11/21/11	CI
Expres2ion Biotech Holding AB Appoints Keith Alexander as New Chief Financial Officer, Effective October 1, 2020	18/20/18	CI
ExpreS2ion Biotechnologies Announces Change in Chief Executive Officer	20/19/20	CI
ExpreS2ion Biotech Holding AB Re-Appoints Mazars Set Revisionsbyrå AB as Auditor	24/19/24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW